Integrated miR-omics and proteomics reveal the regulatory role of miR in protein networks associated with COVID-19 disease progression.
Saved in:
| Title: | Integrated miR-omics and proteomics reveal the regulatory role of miR in protein networks associated with COVID-19 disease progression. |
|---|---|
| Authors: | Mercer KE; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Vijay V; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Yu LR; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Han T; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Masters EA; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Sun J; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Bidarimath M; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Ramey M; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Agrawal M; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, United States., Flores-Torres AS; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., Green AM; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, United States.; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., Burkhart K; Division of Applied Regulatory Sciences, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, United States., Herzog C; Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Dusio G; Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Arthur JM; Department of Nephrology, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Oliphant J; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States., Smallwood HS; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States., Beger RD; Division of Systems Biology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Sep 14; Vol. 17, pp. 1796638. Date of Electronic Publication: 2026 Sep 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1796638 |
